vs
Esperion Therapeutics, Inc.（ESPR）与FIRST FINANCIAL BANCORP（FFBC）财务数据对比。点击上方公司名可切换其他公司
FIRST FINANCIAL BANCORP的季度营收约是Esperion Therapeutics, Inc.的1.6倍（$271.5M vs $168.4M），过去两年FIRST FINANCIAL BANCORP的营收复合增速更高（12.4% vs 10.6%）
Esperion Therapeutics, Inc.是一家上市美国药企，专注开发用于降低低密度脂蛋白胆固醇的口服小分子药物苯哌多酸，公司总部位于密歇根州安娜堡，目前核心研发管线围绕这款降脂创新药物推进，深耕血脂异常治疗领域的创新药物开发。
第一金融银行集团是总部位于美国俄亥俄州辛辛那提的区域性银行，运营中心设于辛辛那提北郊斯普林代尔及印第安纳州格林斯堡。该行成立于1863年，拥有美国第六悠久的国家银行牌照，在俄亥俄、印第安纳、肯塔基、伊利诺伊四州共设有131个营业网点，2009年9月曾在政府协助下收购欧文金融公司及其子公司。
ESPR vs FFBC — 直观对比
营收规模更大
FFBC
是对方的1.6倍
$168.4M
两年增速更快
FFBC
近两年复合增速
10.6%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $168.4M | $271.5M |
| 净利润 | — | $74.4M |
| 毛利率 | — | — |
| 营业利润率 | 50.6% | — |
| 净利率 | — | 27.4% |
| 营收同比 | 143.7% | — |
| 净利润同比 | — | — |
| 每股收益（稀释后） | $0.32 | $0.71 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ESPRFFBC
| Q1 26 | — | $271.5M | ||
| Q4 25 | $168.4M | $238.8M | ||
| Q3 25 | $87.3M | $234.0M | ||
| Q2 25 | $82.4M | $226.3M | ||
| Q1 25 | $65.0M | $200.4M | ||
| Q4 24 | $69.1M | $224.3M | ||
| Q3 24 | $51.6M | $201.3M | ||
| Q2 24 | $73.8M | $214.8M |
净利润ESPRFFBC
| Q1 26 | — | $74.4M | ||
| Q4 25 | — | — | ||
| Q3 25 | $-31.3M | $71.9M | ||
| Q2 25 | $-12.7M | $70.0M | ||
| Q1 25 | $-40.5M | $51.3M | ||
| Q4 24 | — | — | ||
| Q3 24 | $-29.5M | $52.5M | ||
| Q2 24 | $-61.9M | $60.8M |
营业利润率ESPRFFBC
| Q1 26 | — | — | ||
| Q4 25 | 50.6% | — | ||
| Q3 25 | -11.4% | 38.7% | ||
| Q2 25 | 8.6% | 38.8% | ||
| Q1 25 | -34.0% | 31.7% | ||
| Q4 24 | -6.4% | — | ||
| Q3 24 | -31.0% | 32.2% | ||
| Q2 24 | 3.5% | 34.8% |
净利率ESPRFFBC
| Q1 26 | — | 27.4% | ||
| Q4 25 | — | — | ||
| Q3 25 | -35.9% | 30.7% | ||
| Q2 25 | -15.4% | 30.9% | ||
| Q1 25 | -62.2% | 25.6% | ||
| Q4 24 | — | — | ||
| Q3 24 | -57.2% | 26.1% | ||
| Q2 24 | -83.9% | 28.3% |
每股收益（稀释后）ESPRFFBC
| Q1 26 | — | $0.71 | ||
| Q4 25 | $0.32 | $0.64 | ||
| Q3 25 | $-0.16 | $0.75 | ||
| Q2 25 | $-0.06 | $0.73 | ||
| Q1 25 | $-0.21 | $0.54 | ||
| Q4 24 | $-0.14 | $0.68 | ||
| Q3 24 | $-0.15 | $0.55 | ||
| Q2 24 | $-0.33 | $0.64 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $167.9M | — |
| 总债务越低越好 | — | $13.1M |
| 股东权益账面价值 | $-302.0M | $2.9B |
| 总资产 | $465.9M | $22.5B |
| 负债/权益比越低杠杆越低 | — | 0.00× |
8季度趋势，按日历期对齐
现金及短期投资ESPRFFBC
| Q1 26 | — | — | ||
| Q4 25 | $167.9M | — | ||
| Q3 25 | $92.4M | — | ||
| Q2 25 | $86.1M | — | ||
| Q1 25 | $114.6M | — | ||
| Q4 24 | $144.8M | — | ||
| Q3 24 | $144.7M | — | ||
| Q2 24 | $189.3M | — |
总债务ESPRFFBC
| Q1 26 | — | $13.1M | ||
| Q4 25 | — | $514.1M | ||
| Q3 25 | — | $221.8M | ||
| Q2 25 | — | $345.0M | ||
| Q1 25 | — | $345.9M | ||
| Q4 24 | — | $347.5M | ||
| Q3 24 | — | $344.1M | ||
| Q2 24 | — | $338.6M |
股东权益ESPRFFBC
| Q1 26 | — | $2.9B | ||
| Q4 25 | $-302.0M | $2.8B | ||
| Q3 25 | $-451.4M | $2.6B | ||
| Q2 25 | $-433.5M | $2.6B | ||
| Q1 25 | $-426.2M | $2.5B | ||
| Q4 24 | $-388.7M | $2.4B | ||
| Q3 24 | $-370.2M | $2.5B | ||
| Q2 24 | $-344.2M | $2.3B |
总资产ESPRFFBC
| Q1 26 | — | $22.5B | ||
| Q4 25 | $465.9M | $21.1B | ||
| Q3 25 | $364.0M | $18.6B | ||
| Q2 25 | $347.1M | $18.6B | ||
| Q1 25 | $324.0M | $18.5B | ||
| Q4 24 | $343.8M | $18.6B | ||
| Q3 24 | $314.1M | $18.1B | ||
| Q2 24 | $352.3M | $18.2B |
负债/权益比ESPRFFBC
| Q1 26 | — | 0.00× | ||
| Q4 25 | — | 0.19× | ||
| Q3 25 | — | 0.08× | ||
| Q2 25 | — | 0.13× | ||
| Q1 25 | — | 0.14× | ||
| Q4 24 | — | 0.14× | ||
| Q3 24 | — | 0.14× | ||
| Q2 24 | — | 0.15× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $45.2M | — |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | 0.0% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流ESPRFFBC
| Q1 26 | — | — | ||
| Q4 25 | $45.2M | $337.9M | ||
| Q3 25 | $-4.3M | $89.8M | ||
| Q2 25 | $-31.4M | $69.8M | ||
| Q1 25 | $-22.6M | $56.1M | ||
| Q4 24 | $-35.0M | $262.2M | ||
| Q3 24 | $-35.3M | $88.1M | ||
| Q2 24 | $-7.2M | $68.1M |
自由现金流ESPRFFBC
| Q1 26 | — | — | ||
| Q4 25 | — | $317.1M | ||
| Q3 25 | — | $85.8M | ||
| Q2 25 | — | $64.8M | ||
| Q1 25 | — | $52.4M | ||
| Q4 24 | — | $241.1M | ||
| Q3 24 | $-35.5M | $84.4M | ||
| Q2 24 | $-7.3M | $64.8M |
自由现金流率ESPRFFBC
| Q1 26 | — | — | ||
| Q4 25 | — | 132.8% | ||
| Q3 25 | — | 36.7% | ||
| Q2 25 | — | 28.6% | ||
| Q1 25 | — | 26.1% | ||
| Q4 24 | — | 107.5% | ||
| Q3 24 | -68.7% | 42.0% | ||
| Q2 24 | -9.9% | 30.2% |
资本支出强度ESPRFFBC
| Q1 26 | — | — | ||
| Q4 25 | 0.0% | 8.7% | ||
| Q3 25 | 0.0% | 1.7% | ||
| Q2 25 | 0.0% | 2.2% | ||
| Q1 25 | 0.0% | 1.9% | ||
| Q4 24 | 0.0% | 9.4% | ||
| Q3 24 | 0.3% | 1.8% | ||
| Q2 24 | 0.1% | 1.5% |
现金转化率ESPRFFBC
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | 1.25× | ||
| Q2 25 | — | 1.00× | ||
| Q1 25 | — | 1.09× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 1.68× | ||
| Q2 24 | — | 1.12× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ESPR
| Collaboration Revenue | $124.7M | 74% |
| Products | $43.7M | 26% |
FFBC
| Net Interest Income | $189.6M | 70% |
| Noninterest Income | $81.9M | 30% |
